DC

Driehaus Capital Management

North America, Illinois, United States, Chicago

Description

Driehaus is an investment management firm that manages growth equity investment strategies and multi-asset alternative strategies.

Investor Profile

Driehaus Capital Management has made 41 investments, with 7 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (39%)
  • Series B (24%)
  • Series C (15%)
  • Series A (7%)
  • Series Unknown (5%)
  • Series E (2%)
  • Series G (2%)
  • Seed (2%)
  • Undisclosed (2%)

Country Focus

  • United States (88%)
  • United Kingdom (2%)
  • Switzerland (2%)
  • Belgium (2%)
  • Canada (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Health Diagnostics
  • Life Science
  • Oncology
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Driehaus Capital Management frequently co-invest with?

Casdin Capital
North America, New York, United States, New York
Co-Investments: 6
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 9
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 7
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 10
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 10
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 6
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 10
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 7
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 8
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 7

Which angels does Driehaus Capital Management often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1
RK
North America, Utah, United States, Salt Lake City
Shared Deals: 1
Clarissa Desjardins
North America, Quebec, Canada, Montréal
Shared Deals: 1

What are some of recent deals done by Driehaus Capital Management?

Olema Oncology

San Francisco, California, United States

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceutical
Post Ipo EquityDec 2, 2024
Amount Raised: $250,000,000

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

BiotechnologyHealth CareMedical Device
UndisclosedOct 29, 2024
Amount Raised: $200,000,000
MBX Biosciences

Carmel, Indiana, United States

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

BiotechnologyHealth CareTherapeutics
Series CAug 5, 2024
Amount Raised: $63,500,000
Jade Biosciences

Waltham, Massachusetts, United States

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Health CareTherapeutics
Series AAug 1, 2024
Amount Raised: $80,000,000
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
Celcuity

Hamel, Minnesota, United States

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo EquityMay 30, 2024
Amount Raised: $60,000,000
Context Therapeutics

Philadelphia, Pennsylvania, United States

Context Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyHealth Care
Post Ipo EquityMay 2, 2024
Amount Raised: $100,000,000
Alterome Therapeutics

San Diego, California, United States

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

BiopharmaBiotechnologyPharmaceutical
Series BApr 3, 2024
Amount Raised: $132,000,000
MindMed

New York, New York, United States

MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityMar 7, 2024
Amount Raised: $175,000,000
Crinetics Pharmaceuticals

San Diego, California, United States

Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityFeb 28, 2024
Amount Raised: $350,000,000